These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 2943228

  • 1. [Immune reactivities of lymphocytes from peripheral blood, regional lymph nodes and tumor-infiltrating lymphocytes in breast cancer].
    Hisamatsu K, Toge T, Yanagawa E, Hamada Y, Seto Y, Yamada H, Toi M, Hattori T.
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2555-61. PubMed ID: 2943228
    [Abstract] [Full Text] [Related]

  • 2. Functional and surface phenotype study of lymphocyte subsets in peripheral blood and lymph nodes of breast cancer patients.
    Mantovani G, Serri FG, Macciò A, Castelli P, Benedetti P, Scambia G, Santus S, Paderi R, Murtas MG, Ferreli A.
    Cancer Detect Prev; 1989 Aug; 13(5-6):323-32. PubMed ID: 2743354
    [Abstract] [Full Text] [Related]

  • 3. Immunoreactivity of lymphocytes from draining lymph nodes, peripheral blood and tumor infiltrates from oral cancer patients.
    Mukhopadhyaya R, Tatake RJ, Krishnan N, Rao RS, Fakih AR, Naik SL, Gangal SG.
    J Clin Lab Immunol; 1989 Sep; 30(1):21-5. PubMed ID: 2641790
    [Abstract] [Full Text] [Related]

  • 4. Induction of lymphokine-activated killer activities in peripheral blood lymphocytes and regional lymph node lymphocytes against PC-9 cultured adenocarcinoma and autologous pulmonary adenocarcinoma cells.
    Morikawa Y, Watanabe S, Kodama T.
    Jpn J Clin Oncol; 1987 Jun; 17(2):129-39. PubMed ID: 3497285
    [Abstract] [Full Text] [Related]

  • 5. Functional analysis of tumor-infiltrating leukocytes in breast cancer patients.
    Wong PY, Staren ED, Tereshkova N, Braun DP.
    J Surg Res; 1998 Apr; 76(1):95-103. PubMed ID: 9695747
    [Abstract] [Full Text] [Related]

  • 6. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G, Spuzić I.
    Srp Arh Celok Lek; 1995 Apr; 123(9-10):227-31. PubMed ID: 17974436
    [Abstract] [Full Text] [Related]

  • 7. Deficient concanavalin-A-induced suppressor cell activity in women with untreated breast cancer.
    Gupta S, Cunningham-Rundles S.
    J Clin Lab Immunol; 1982 Dec; 9(3):159-61. PubMed ID: 6220154
    [Abstract] [Full Text] [Related]

  • 8. Generation of suppressor cells for natural killer activity in cancer patients after surgery.
    Uchida A, Kolb R, Micksche M.
    J Natl Cancer Inst; 1982 May; 68(5):735-41. PubMed ID: 6461792
    [Abstract] [Full Text] [Related]

  • 9. Monoclonal antibody-defined phenotypes of regional lymph node and peripheral blood lymphocyte subpopulations in early breast cancer.
    Morton BA, Ramey WG, Paderon H, Miller RE.
    Cancer Res; 1986 Apr; 46(4 Pt 2):2121-6. PubMed ID: 3081262
    [Abstract] [Full Text] [Related]

  • 10. Cytolysis of mammary tumor targets by resting, interleukin-2 stimulated and in vitro cultured peripheral blood lymphocytes from breast cancer patients.
    Brenner BG, McCrea EL, Margolese RG.
    Anticancer Res; 1988 Apr; 8(4):653-8. PubMed ID: 3263077
    [Abstract] [Full Text] [Related]

  • 11. Suppressor cell activity in melanoma-draining lymph nodes.
    Hoon DS, Bowker RJ, Cochran AJ.
    Cancer Res; 1987 Mar 15; 47(6):1529-33. PubMed ID: 2949828
    [Abstract] [Full Text] [Related]

  • 12. Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors.
    Miescher S, Whiteside TL, Moretta L, von Fliedner V.
    J Immunol; 1987 Jun 01; 138(11):4004-11. PubMed ID: 3108380
    [Abstract] [Full Text] [Related]

  • 13. Natural killer cell activity in the perigastric lymph nodes from patients with gastric carcinoma or benign lesions.
    Koba F, Akiyoshi T, Tsuji H.
    J Clin Lab Immunol; 1987 Aug 01; 23(4):191-5. PubMed ID: 2959787
    [Abstract] [Full Text] [Related]

  • 14. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
    Kimura H, Dobrenkov K, Iida T, Suzuki M, Ando S, Yamamoto N.
    Anticancer Res; 2005 Aug 01; 25(1A):85-94. PubMed ID: 15816523
    [Abstract] [Full Text] [Related]

  • 15. Immunologic phenotype and function in human bone marrow, blood stem cells and umbilical cord blood.
    Mills KC, Gross TG, Varney ML, Heimann DG, Reed EC, Kessinger A, Talmadge JE.
    Bone Marrow Transplant; 1996 Jul 01; 18(1):53-61. PubMed ID: 8831996
    [Abstract] [Full Text] [Related]

  • 16. Study of tumor-associated blastogenic reactivity of peripheral blood lymphocytes and regional lymph node lymphocytes in human malignancy.
    Kurosu Y, Saegusa Y, Tominaga M, Morita K.
    Jpn J Clin Oncol; 1983 Mar 01; 13(1):25-30. PubMed ID: 6834651
    [Abstract] [Full Text] [Related]

  • 17. Natural killer cell activity in tumor-draining lymph nodes: investigations in patients with malignant melanoma and head and neck cancer.
    Micksche M, Vinzenz K, Kokoschka EM, Kokoschka R.
    Nat Immun Cell Growth Regul; 1985 Mar 01; 4(6):315-27. PubMed ID: 4088287
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD, Ravaggi A, Bellone S, Pecorelli S, Cannon M, Parham GP, Hermonat PL.
    Gynecol Oncol; 2001 Jun 01; 81(3):424-32. PubMed ID: 11371133
    [Abstract] [Full Text] [Related]

  • 20. [Interferon production in lymph nodes draining breast carcinoma and its augmentation by OK-432].
    Nakajima Y, Akimoto M, Kimura M, Matano S, Hirakawa H, Kasai M.
    Gan To Kagaku Ryoho; 1986 Sep 01; 13(9):2766-71. PubMed ID: 2428312
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.